The R&D 15: How pharma's top companies spent, won and lost on drug research

April 30, 2026 07:15 AM EDT BioregnumSpecialPharma The R&D 15: The stakes need­ed to play in the world's biggest drug re­search groups re­quire very deep pock­ets John Carroll Editor & Founder Talk­ing over phar­ma pipelines with a ma­jor drug­mak­er’s de­vel­op­ment chief, he not­ed that if you looked at the biggest 50 drugs by rev­enue, the fi­nal … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER